NEW YORK -- A new study suggests people in the early stages of multiple sclerosis may be helped by a vaccine used to prevent tuberculosis.
Some in the study received the live vaccine.
After five years, 58-percent of those vaccinated were free of MS compared to 30-percent of those who were not vaccinated.
The key may be the exposure to the vaccine's live virus.
Copyright 2013 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.